Valuation: Toho Holdings Co., Ltd.

Market Cap 258B 1.62B 1.41B 1.31B 1.2B 2.27B 154B 2.3B 15.43B 6.05B 76.87B 6.07B 5.94B P/E 2027 *
20.8x
P/E 2028 * 19.3x
Enterprise Value 258B 1.62B 1.41B 1.31B 1.2B 2.27B 154B 2.3B 15.43B 6.05B 76.87B 6.07B 5.94B EV / Sales 2027 *
0.16x
EV / Sales 2028 * 0.16x
Free-Float
76.64%
Yield 2027 *
4.52%
Yield 2028 * 4.08%
06-30 Toho Holdings Co., Ltd. agreed to acquire an unknown majority stake in Ishin Pharma Co., Ltd. CI
06-30 GNI Group Ltd. completed the acquisition of AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. CI
06-17 3D Investment Partners Pte. Ltd. Urges Shareholders of Toho Holdings Co., Ltd. CI
06-09 Toho Holdings Co., Ltd. Urging Shareholders to Vote Against Poison Pill Proposal CI
06-07 GNI to Acquire Ayumi Pharmaceutical in 44.8 Billion Yen Deal; Blackstone-Backed Fund Becomes Top Shareholder MT
06-04 GNI Group Ltd. agreed to acquire AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. for ¥44.8 billion. CI
06-01 3D Investment Partners Urges Shareholders to Vote Against Toho HD?s Proposal 4 Poison Pill CI
05-13 Toho Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-10 MP-2605 K.K. completed the acquisition of 53.42% stake in Solasto Corporation from Daito Trust Construction Co.,Ltd., Toho Holdings Co., Ltd., Goldman Sachs International, JPMorgan Securities Japan Co., Ltd., Medical Concierge Co., Ltd., The Master Trust Bank of Japan, Ltd., Custody Bank of Japan, Ltd. and others for ¥54.12 billion. CI
05-07 Japan's Listed Companies Face Investor Pressure on 20 Trillion Yen Real Estate Gains MT
04-30 Japan Shares Drop on Soft Output Data, Middle East Risks MT
04-29 Toho Holdings Flags Risks in 3D Investment Stake Build, Plans Vote on Proposed Acquisition MT
04-28 Toho Holdings Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ended March 31, 2026 CI
1 day-0.75%
1 week-2.85%
Current month-0.75%
1 month+3.53%
3 months-8.48%
6 months-13.78%
Current year-14.65%
1 week 3,873
Extreme 3873
4,403
1 month 3,866
Extreme 3866
4,403
Current year 3,729
Extreme 3729
5,031
1 year 3,729
Extreme 3729
5,726
3 years 2,681.5
Extreme 2681.5
5,726
5 years 1,678
Extreme 1678
5,726
10 years 1,653
Extreme 1653
5,726
Manager TitleAgeSince
Chief Executive Officer 74 2024-06-26
Director of Finance/CFO - -
Chief Operating Officer 61 2022-05-31
Director TitleAgeSince
Director/Board Member 60 2001-05-31
Director/Board Member 74 2015-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-2.85%-22.10%+45.06% 1.63B
-0.71%+0.36%+20.00%+96.06% 100B
+0.98%+1.18%+46.29%+147.47% 53.87B
+1.02%+4.58%+3.85%+278.34% 23.74B
-0.30%+2.63%-12.90%-14.50% 8.37B
-1.86%-0.03%-34.67%-31.07% 7.56B
+0.46%+3.68%-7.32%-27.10% 6.92B
-2.80%-3.45%+19.42%+17.61% 6.16B
-1.02%-2.52%-2.52%+22.05% 5.29B
0.00%+2.79%-6.02%-2.09% 3.8B
Average -0.49%+0.86%+0.40%+53.18% 21.76B
Weighted average by Cap. -0.06%+1.55%+19.38%+109.97%

Financials

2027 *2028 *
Net sales 1,601B 10.05B 8.73B 8.13B 7.46B 14.09B 959B 14.31B 95.81B 37.6B 477B 37.73B 36.9B 1,635B 10.26B 8.92B 8.3B 7.62B 14.39B 979B 14.61B 97.83B 38.4B 487B 38.52B 37.68B
Net income 12.14B 76.21M 66.25M 61.67M 56.62M 107M 7.28B 109M 727M 285M 3.62B 286M 280M 13.54B 85M 73.89M 68.77M 63.14M 119M 8.11B 121M 811M 318M 4.04B 319M 312M
Net Debt - -
Logo Toho Holdings Co., Ltd.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Employees
7,675
Date Price Change Volume
26-08-03 JP¥3,984.00 -0.75% 158,100
26-07-31 JP¥4,014.00 -3.93% 548,400
26-07-30 JP¥4,178.00 -3.24% 275,900
26-07-29 JP¥4,318.00 +2.32% 202,700
26-07-28 JP¥4,220.00 +0.02% 165,500
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4,014.00JPY
Average target price
4,325.00JPY
Spread / Average Target
+7.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 8129 Stock